Tag : Cannabinoid

Cardiology

Mechanisms for the Risk of Acute Coronary Syndrome and Arrhythmia Associated With Phytogenic and Synthetic Cannabinoid Use.

Newsemia
Related Articles Mechanisms for the Risk of Acute Coronary Syndrome and Arrhythmia Associated With Phytogenic and Synthetic Cannabinoid Use. J Cardiovasc Pharmacol Ther. 2020 11;25(6):508-522...
Latest News

IGC Reports Financial Results for September 30, 2020 Quarter and Start of Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients

Newsemia
POTOMAC, Md.–(BUSINESS WIRE)– #AD–India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the quarter ended September 30,...
Neurology

Marijuana Use Tied to Repeat MI, Stroke After PCI

Newsemia
Cannabis users were more likely to have a second MI, especially if middle-aged, Black, or male, and they had a higher risk of bleeding or...
Neurology

CBD Users May Test Positive for Marijuana on Urine Drug Screen

Newsemia
Tetrahydrocannabinol, the psychoactive ingredient in marijuana, was found in 50% of urine samples from individuals using cannabidiol oil (CBD). Medscape Medical News Source link...
Neurology

How Cannabis-Based Therapeutics Could Help Fight COVID Inflammation

Newsemia
Researchers specializing in cannabinoid therapeutics believe such therapies have a special role to play in treating COVID-19 and the cytokine storm. Medscape Medical News Source...
Latest News

GMU researchers studying effect of cannabidiol on exosome release

Newsemia
Fatah Kashanchi, Professor, Laboratory of Molecular Virology, School of Systems Biology, and Lance Liotta, Co-Director, Applied Proteomics and Molecular Medicine, are working to mitigate virally...
Latest News

GB Sciences announces preclinical results of promising formulations for Parkinson's disease

Newsemia
GB Sciences, Inc. announced significant preclinical results for their Parkinson’s disease (“PD”) formulations from the midterm report for their preclinical study being performed by Dr....
Pharma / Biotech

Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice.

Newsemia
Related Articles Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice. Pharmacol...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy